Major Role for 5-Alpha Reductase Inhibitors in the Aging Male
December 2012
in “
Canadian Urological Association Journal
”
Studysummary This consensus summary suggests that 5-alpha reductase inhibitors have clear benefits for benign prostatic hyperplasia, but their impact on prostate cancer prevention is still debated.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on cuaj.ca →